Invention Grant
US09526742B2 Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder
有权
表观遗传改变化合物用于治疗与蛋白质构象紊乱相关的遗传性肌肉疾病的用途
- Patent Title: Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder
- Patent Title (中): 表观遗传改变化合物用于治疗与蛋白质构象紊乱相关的遗传性肌肉疾病的用途
-
Application No.: US14407211Application Date: 2013-07-16
-
Publication No.: US09526742B2Publication Date: 2016-12-27
- Inventor: Isabelle Richard
- Applicant: GENETHON
- Applicant Address: FR Evry
- Assignee: GENETHON
- Current Assignee: GENETHON
- Current Assignee Address: FR Evry
- Agency: Seed IP Law Group LLP
- Priority: FR1257021 20120719
- International Application: PCT/FR2013/051705 WO 20130716
- International Announcement: WO2014/013184 WO 20140123
- Main IPC: A61K31/706
- IPC: A61K31/706 ; A61K31/167 ; G01N33/50 ; A61K31/7068
Abstract:
A pharmaceutical composition including at least one epigenome-modifying compound, for a use thereof in the treatment of genetic muscular diseases linked to a conformational disorder of at least one protein, said disorder causing the cellular degradation of the protein.
Public/Granted literature
Information query
